Search results
Nearly Two-Thirds of People on Weight Loss Drugs Stop Due to Side Effects, Other Concerns
The Fairfax County Times· 5 days agoThe majority of patients prescribed weight loss drugs for obesity stop taking them because of side effects and cost, according to the results of a new survey from HealthCentral ...
Coalition urges DoD to tackle obesity epidemic
Federal News Network· 1 day agoTom Temin And in this letter to Secretary Austin, you’re saying that obesity is an existential threat to the U.S. military. Courtney Manning...
Curbing the price of novel diabetes and obesity medications
Medical Xpress· 4 days agoIn subsequent research, Lipska discovered that 1.1 million Americans, or 14 percent of those who filled insulin prescriptions, reached catastrophic spending, defined as spending more than 40 ...
Opinion | Patients Hitting GLP-1 Plateaus? Here's How to Help
MedPage Today· 4 days agoDrugs like semaglutide (Wegovy) and tirzepatide (Zepbound) are changing the game in obesity care. In...
Does Medicare cover Ozempic? - WTOP News
WTOP Washington· 2 days agoAs the overall population ages, there is a growing prevalence of diabetes among adults ages 65 and older. In fact, about 16.5 million people in this age...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
Over 70% of Low-Income Women Have No Confidence in Their Ability To Plan for Retirement — 8...
GOBankingRates via Yahoo Finance· 3 days ago“The problem is that Medicare does not cover the full range of obesity treatments,” she wrote. “It...
TIME100 Health: Lars Fruergaard Jorgensen
Time via Yahoo News· 2 days ago“Most medicines in obesity had failed, and some of them were even turning out to be dangerous and leading to undesirable...also released results showing...
Column: Fears about 'Ozempic babies' show how woeful U.S. women's healthcare really is
LA Times via Yahoo News· 18 hours agoJust as women's reproductive rights are being restricted, a flurry of troubling reports about...
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg· 4 days agoEli Lilly & Co.’s shares jumped after it raised its annual guidance on soaring demand for its...
